THC Slowed Thinking More in Lighter Cannabis Users Than Heavier Ones
In a placebo-controlled experiment with 30 young cannabis users, THC did not impair cognitive efficiency on average, but individuals with less recent cannabis use showed greater cognitive slowing.
Quick Facts
What This Study Found
Overall, 7.5mg oral THC did not significantly alter cognitive performance compared to placebo. However, there was high variability between individuals. Those with less recent cannabis use experienced greater cognitive slowing (slower drift rates), and those who reported stronger subjective drug effects also showed poorer cognitive efficiency.
Key Numbers
N=30, ages 18-25, 53% men. Dose: 7.5mg oral THC vs placebo. No significant overall group effects on drift rate, boundary separation, or non-decision time. Less recent cannabis use predicted greater cognitive slowing. Stronger subjective "high" and "effect" ratings correlated with poorer cognitive efficiency.
How They Did This
Double-blind, placebo-controlled THC administration experiment with 30 occasional to regular cannabis users aged 18-25. Participants completed a Go/No-Go task at peak drug effect under both conditions. Data were analyzed using drift diffusion modeling and Bayesian statistics.
Why This Research Matters
This study helps explain why THC impairment research produces mixed results: the effects vary dramatically between individuals based on their tolerance level. Computational modeling reveals heterogeneity that traditional analyses may miss.
The Bigger Picture
The concept of cannabis tolerance is well-known anecdotally, but this study provides computational evidence that tolerance genuinely reduces acute cognitive impairment from THC. This has implications for impairment testing, workplace policies, and understanding individual risk.
What This Study Doesn't Tell Us
Small sample (N=30) of young, experienced cannabis users. Single dose level (7.5mg) limits generalizability. Only one cognitive task (Go/No-Go). Cannot determine whether tolerance-related differences reflect neuroadaptation or behavioral compensation.
Questions This Raises
- ?At what point does tolerance develop enough to meaningfully reduce cognitive impairment?
- ?Do these findings extend to higher THC doses?
- ?How should individual differences in tolerance be accounted for in impairment testing?
Trust & Context
- Key Stat:
- Less recent cannabis use predicted greater cognitive slowing from THC
- Evidence Grade:
- Preliminary evidence from a small but well-designed placebo-controlled experiment with computational modeling.
- Study Age:
- 2025 study using advanced computational methods to examine THC effects on cognition.
- Original Title:
- Acute effects of Δ9-tetrahydrocannabinol on computational measures of neurocognitive processes are related to recent cannabis use among adolescents and young adults.
- Published In:
- Frontiers in adolescent medicine, 3 (2025)
- Authors:
- Paige, K J, Weigard, A S, Ajilore, O, Phan, K L, de Wit, H, Klumpp, H, Crane, N A
- Database ID:
- RTHC-07297
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Did THC impair thinking in this study?
On average, no. But the effects varied widely between individuals. People who used cannabis less recently showed more cognitive slowing after THC, while more frequent users showed less impairment, consistent with tolerance.
How was tolerance measured?
Researchers used recent cannabis use frequency and subjective drug effects (how "high" participants felt) as indicators. Those with less recent use and stronger subjective effects showed greater cognitive impairment.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-developing-brain-teenagers
- cannabis-perception-vs-evidence-gap
- cannabis-use-disorder-test
- cant-enjoy-anything-without-weed
- cross-addiction-quit-weed-start-drinking
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- is-weed-addictive
- is-weed-addictive-science
- nervous-system-weed-withdrawal-fight-flight
- quitting-weed-and-alcohol
- rehab-for-weed-addiction-necessary
- signs-of-cannabis-use-disorder
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-07297APA
Paige, K J; Weigard, A S; Ajilore, O; Phan, K L; de Wit, H; Klumpp, H; Crane, N A. (2025). Acute effects of Δ9-tetrahydrocannabinol on computational measures of neurocognitive processes are related to recent cannabis use among adolescents and young adults.. Frontiers in adolescent medicine, 3. https://doi.org/10.3389/fradm.2025.1541068
MLA
Paige, K J, et al. "Acute effects of Δ9-tetrahydrocannabinol on computational measures of neurocognitive processes are related to recent cannabis use among adolescents and young adults.." Frontiers in adolescent medicine, 2025. https://doi.org/10.3389/fradm.2025.1541068
RethinkTHC
RethinkTHC Research Database. "Acute effects of Δ9-tetrahydrocannabinol on computational me..." RTHC-07297. Retrieved from https://rethinkthc.com/research/paige-2025-acute-effects-of-9tetrahydrocannabinol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.